Enjoy complimentary customisation on priority with our Enterprise License!
The bio-detection market is estimated to grow by USD 12,270.05 million at a CAGR of 12.96% between 2022 and 2027. The growth of the market depends on several factors, including the increasing incidence of infectious diseases and cancer, increasing initiatives for rapid diagnostics of diseases, and the increasing number of alliances.
It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
The increasing incidence of infectious diseases and cancer is notably driving the market growth, although factors such as inadequate healthcare services in developing regions may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Driver
The increasing incidence of infectious diseases is notably driving the biodetectors and accessories market growth. The prevalence of infectious diseases such as tuberculosis, human immunodeficiency virus (HIV), pneumonia, and malaria has increased. HIV attacks, for example, eventually destroy the immune system, resulting in Acquired immunodeficiency syndrome (AIDS), although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised.
There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes. For instance, the Aid for AIDS program understands the needs of patients and provides them with the required treatments and tools to lead normal lives. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to boost the growth of the global market significantly during the forecast period.
Significant Trend
The increasing applications of microorganisms are an emerging trend in the market. Microorganisms are increasingly being used for producing various products, such as food items and beverages, food additives and supplements, and microbial enzymes. These products are of economic importance. Industrial microbiologists perform various activities for producing commercial products from microorganisms, these activities include the isolation of microorganisms from nature, screening for product formations, maintaining cultures, and retrieving products, followed by their purification. All these activities require bio-detection products such as microbial identification systems, kits, and reagents.
Some products manufactured with the help of microorganisms are beverages and amino acids. Microorganisms such as yeasts are used to produce beverages such as beer, wine, whiskey, brandy, and rum. Microorganisms also help produce amino acids such as lysine and glutamic acid, which are used in the food industry as nutritional supplements in bread products. Hence, the increased use of microorganisms in the production of food and beverage products is expected to drive the growth of the global biodetectors and accessories market during the forecast period.
Major Challenge
The inadequate healthcare services in developing regions is a major challenge impeding market growth. Many people in developing regions do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by the lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as bio-detection.
Countries such as Afghanistan and Bangladesh are grappling with the lack of technology and the appropriate policies to enable the delivery of healthcare services. The stigma or misconception about the gravity of conditions such as sexually transmitted diseases (STDs) further discourages any form of testing, including microbiology testing and the subsequent treatment of infectious diseases. Hence, all of the abovementioned factors will hinder the growth of the global market during the forecast period.
Key Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Bertin Technologies SAS - The company designs and manufactures measurement, observation, detection systems, and instruments for critical applications. The key offerings of the company include bio-detection.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the clinical segment will be significant during the forecast period. The clinical segment was a leading segment in the global market in 2022 owing to increasing demand from critically ill patients after the pandemic and the increasing geriatric population across the world.
Get a glance at the market contribution of various segments Request a PDF Sample
The clinical segment was valued at USD 4,396.92 million in 2017 and continued to grow until 2021. There are increasing cases of infectious diseases such as influenza and measles in developed and developing countries across the world, which, in turn, increases the demand for bio-detection in clinics. This will be the primary factor that will be responsible for driving the segment growth during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America was the largest revenue contributor to the global market in 2022, with the US being the leading country. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several companies in the country offering a wide range of bio-detection products are aiding the growth of the market.
The market in North America is led by the US and Canada owing to the increase in focus on drug discovery and development by several pharmaceutical companies, such as Novartis and Pfizer. R&D for drug development and diagnosis of diseases requires bio-detection products. The drug discovery market is expected to grow owing to the emergence of new fatal diseases, the high prevalence of infectious diseases such as respiratory infections and sexually transmitted diseases, and the increased demand for personalized medicines. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of bio-detection in the region, which in turn, will boost the regional market growth during the forecast period.
The market report forecasts market growth by revenue at global, regional & country levels and analyzes the market growth and trends opportunities from 2017 to 2027.
The market is advancing rapidly, driven by Biosecurity measures and the adoption of cutting-edge technologies like Nanotechnology and Sensor technologies. Increased Defense and homeland security budgets are fueling research and development in this field, leading to International collaborations for improved bio-threat detection.
Innovations such as Point-of-Care (POC) Biothreat Detection and Next-Generation Sequencing (NGS) are enhancing detection capabilities. Artificial Intelligence (AI) and Machine Learning (ML) are being integrated into systems to enable Advanced sensor technologies and Real-time and continuous monitoring. Multi-modal detection approaches and the Integration of AI and ML are improving accuracy and speed in detecting bio-threats. The market is also witnessing advancements in Rapid point-of-care diagnostics and Bioinformatics, facilitating efficient Data integration and Information sharing for better bio-threat management.
Bio-detection Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.96% |
Market growth 2023-2027 |
USD 12,270.05 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
12.0 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
20/20 GeneSystems Inc., 3M Co., Abbott Laboratories, AdVnt Biotechnologies LLC, Agilent Technologies Inc., Alexeter Technologies LLC, Bertin Technologies SAS, Bio Rad Laboratories Inc., Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Illumina Inc., MBio Diagnostics Inc., Physical Sciences Inc., PositiveID Corp., Research International Inc., Response Biomedical Corp., Sense Biodetection Inc, Smiths Group Plc, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data you are looking for, you can reach out to our analysts and get customized segments. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.